Fluorescein angiographic findings and Behcet's disease ocular attack score 24 (BOS24) as prognostic factors for visual outcome in patients with ocular Behcet's disease

被引:10
作者
Keorochana, Narumon [1 ]
Homchampa, Nathamon [2 ]
Vongkulsiri, Sritatath [3 ]
Choontanom, Raveewan [4 ]
机构
[1] Phramongkutklao Hosp, Dept Ophthalmol, Ocular Inflammatory & Uveitis Div, 315 Ratchvidhi Rd, Bangkok 10400, Thailand
[2] Phramongkutklao Hosp, Dept Ophthalmol, 315 Ratchvidhi Rd, Bangkok 10400, Thailand
[3] Phramongkutklao Hosp, Dept Ophthalmol, Retina Div, 315 Rajawithi Rd, Bangkok 10400, Thailand
[4] Phramongkutklao Hosp, Dept Ophthalmol, Oculoplast & Reconstruct Surg Div, 315 Rajawithi Rd, Bangkok 10400, Thailand
关键词
Fluorescein Angiography; BOS24; Behcet's disease; Visual prognosis; Ocular Behcet; UVEITIS; ACUITY; NEOVASCULARIZATION; MANIFESTATIONS; FEATURES;
D O I
10.1186/s40942-021-00318-4
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose To determine the application of fluorescein angiographic (FA) findings and Behcet's disease ocular attack score 24 (BOS24) scoring system in predicting poor visual outcome in patients with ocular Behcet's disease. Study design Retrospective cohort study. Methods We included 73 eyes of 38 patients with ocular Behcet's disease who underwent FA and reviewed FA images, anterior chamber cells, vitreous opacity, retinal and optic disc lesions, which are parameters in BOS24. The correlation between FA findings, BOS24, and visual acuity was assessed. Results Optic disc hyperfluoresence (74%), diffuse posterior pole leakage (52%) and diffuse peripheral leakage (52%) were the three most common findings. Common complications were peripheral capillary nonperfusion (29%), arterial narrowing (22%), and macular ischemia (19%). BOS24 scores of >= 6 (p < 0.0001), arterial narrowing (p < 0.0001), and severe posterior pole leakage (p = 0.004) were significantly associated with poor visual outcome. Combining significant FA findings: arterial narrowing and severe posterior pole leakage, to BOS24 >= 6 results in an increased relative risk of developing poor visual acuity from 7.30 to 10.43 and 1.89 to 2.02 respectively. Conclusion Fluorescein angiography is an important investigation for predicting poor visual outcome. BOS24 may be a useful alternative when fluorescein angiographic is unavailable.
引用
收藏
页数:10
相关论文
共 32 条
[11]   Indocyanine green and fundus fluorescein angiographic findings in patients with active ocular Behcet's disease [J].
Gedik, S ;
Akova, YA ;
Yilmaz, G ;
Bozbeyoglu, S .
OCULAR IMMUNOLOGY AND INFLAMMATION, 2005, 13 (01) :51-58
[12]   OCULAR NEOVASCULARIZATION - KRILL MEMORIAL LECTURE [J].
HENKIND, P .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1978, 85 (03) :287-301
[13]   Behcet's disease ocular attack score 24: evaluation of ocular disease activity before and after initiation of infliximab [J].
Kaburaki, Toshikatsu ;
Namba, Kenichi ;
Sonoda, Koh-hei ;
Kezuka, Takeshi ;
Keino, Hiroshi ;
Fukuhara, Takako ;
Kamoi, Koju ;
Nakai, Kei ;
Mizuki, Nobuhisa ;
Ohguro, Nobuyuki .
JAPANESE JOURNAL OF OPHTHALMOLOGY, 2014, 58 (02) :120-130
[14]   Ocular Inflammation in Behcet Disease: Incidence of Ocular Complications and of Loss of Visual Acuity [J].
Kacmaz, R. Oktay ;
Kempen, John H. ;
Newcomb, Craig ;
Gangaputra, Sapna ;
Daniel, Ebenezer ;
Levy-Clarke, Grace A. ;
Nussenblatt, Robert B. ;
Rosenbaum, James T. ;
Suhler, Eric B. ;
Thorne, Jennifer E. ;
Jabs, Douglas A. ;
Foster, C. Stephen .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2008, 146 (06) :828-836
[15]   Evaluation of disease activity in uveoretinitis associated with Behcet's disease [J].
Keino, Hiroshi .
IMMUNOLOGICAL MEDICINE, 2021, 44 (02) :86-97
[16]   Correlation between Fluorescein Angiographic Findings and Visual Acuity in Behcet Retinal Vasculitis [J].
Kim, Min ;
Kwon, Hee Jung ;
Choi, Fun Young ;
Kim, Sung Soo ;
Koh, Hyoung Jun ;
Lee, Sung Chul .
YONSEI MEDICAL JOURNAL, 2015, 56 (04) :1087-1096
[17]   Ocular features of Behcet's disease: An international collaborative study [J].
Kitaichi, Nobuyoshi ;
Miyazaki, Akiko ;
Stanford, Miles R. ;
Chams, Hormoz ;
Iwata, Daiju ;
Ohno, Shigeaki .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2007, 91 (12) :1579-1582
[18]  
Lee S., 2007, INVEST OPHTHALMOL VI, V48, P5128
[19]   Expert Panel Recommendations for the Use of Anti-Tumor Necrosis Factor Biologic Agents in Patients with Ocular Inflammatory Disorders [J].
Levy-Clarke, Grace ;
Jabs, Douglas A. ;
Read, Russell W. ;
Rosenbaum, James T. ;
Vitale, Albert ;
Van Gelder, Russell N. .
OPHTHALMOLOGY, 2014, 121 (03) :785-U215
[20]   Clinical features, visual outcome, and poor prognostic factors in occlusive retinal vasculitis [J].
Lin, Miaoli ;
Anesi, Stephen D. ;
Chang, Peter Y. ;
Eggenschwiler, Laura ;
Manhapra, Ambika ;
Walsh, Marisa ;
Foster, C. Stephen .
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2022, 57 (03) :207-213